Form 4 for GILD Gilead Sciences
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-10 · accession 0001127602-24-009742 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-12 | 2024-03-10 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | F - Tax | $75.12 | -846 | 13.8K | -6% | -$63.6K |
| D | 2024-03-12 | 2024-03-10 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | — | +2,555 | 14.6K | +21% | — |
| D | 2024-03-12 | 2024-03-10 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | — | -2,555 | 29.3K | -8% | — |
| DM | 2024-03-12 | 2024-03-10 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | A - Grant | $0.00 | +65.8K | 40.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-10 | F | D | 846 | $75.12 | 13,757 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-10 | M | A | 2,555 | — | 14,603 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan. |
| 3 | Derivative | Restricted Stock Unit | 2024-03-10 | M | D | 2,555 | — | 29,268 | D | — · — to — | 2,555 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 4 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-03-10 | A | A | 54,980 | $0.00 | 54,980 | D | $75.12 · — to 2034-03-10 | 54,980 Common Stock | (F4) The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 5 | Derivative | Restricted Stock Unit | 2024-03-10 | A | A | 10,815 | — | 40,083 | D | — · — to — | 10,815 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |